ChemicalBook >> journal list >> Cell reports >>article
Cell reports

Cell reports

IF: 7.5
Download PDF

RPGR is a guanine nucleotide exchange factor for the small GTPase RAB37 required for retinal function via autophagy regulation

Published:23 April 2024 DOI: 10.1016/j.celrep.2024.114010 PMID: 38536817
Ruhong Ying, Cong Li, Huirong Li, Juan Zou, Mengxin Hu, Qiang Hong, Yin Shen, Ling Hou, Hanhua Cheng, Rongjia Zhou

Abstract

Although the small GTPase RAB37 acts as an organizer of autophagosome biogenesis, the upstream regulatory mechanism of autophagy via guanosine diphosphate (GDP)-guanosine triphosphate (GTP) exchange in maintaining retinal function has not been determined. We found that retinitis pigmentosa GTPase regulator (RPGR) is a guanine nucleotide exchange factor that activates RAB37 by accelerating GDP-to-GTP exchange. RPGR directly interacts with RAB37 via the RPGR-RCC1-like domain to promote autophagy through stimulating exchange. Rpgr knockout (KO) in mice leads to photoreceptor degeneration owing to autophagy impairment in the retina. Notably, the retinopathy phenotypes of Rpgr KO retinas are rescued by the adeno-associated virus-mediated transfer of pre-trans-splicing molecules, which produce normal Rpgr mRNAs via trans-splicing in the Rpgr KO retinas. This rescue upregulates autophagy through the re-expression of RPGR in KO retinas to accelerate GDP-to-GTP exchange; thus, retinal homeostasis reverts to normal. Taken together, these findings provide an important missing link for coordinating RAB37 GDP-GTP exchange via the RPGR and retinal homeostasis by autophagy regulation.

Substances (10)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
Torin 1 1222998-36-8 C35H28F3N5O2 191 suppliers $28.00-$4500.00
Torin 1 1222998-36-8 C35H28F3N5O2 191 suppliers $28.00-$4500.00
Torin 1 1222998-36-8 C35H28F3N5O2 191 suppliers $28.00-$4500.00
Torin 1 1222998-36-8 C35H28F3N5O2 191 suppliers $28.00-$4500.00

Similar articles

IF:29.9

The oxytocin receptor system: structure, function, and regulation.

Physiological reviews G. Gimpl, F. Fahrenholz,etc Published: 1 April 2001
IF:6.2

344-OR: The MOTS-c/CK2 Pathway Is a Novel Molecular Target for Type 2 Diabetes in East Asians

Diabetes HIROSHI KUMAGAI, SU JEONG KIM,etc Published: 19 July 2024
IF:3

A comprehensive review on Brigatinib – A wonder drug for targeted cancer therapy in non-small cell lung cancer

Saudi Pharmaceutical Journal Silky Bedi , Shah A. Khan ,etc Published: 1 September 2018